Inovio Pharmaceuticals Bolsters Research and Clinical Development Leadership as it Advances Cancer & Infectious Disease Immunotherapies

[PR Newswire] – BLUE BELL, Pa., Feb. 18, 2014 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has expanded its senior management team with two appointments to help advance the company’s growing pipeline of preclinical and more

View todays social media effects on INO

View the latest stocks trending across Twitter. Click to view dashboard

See who Inovio is hiring next, click here to view